 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Update in Lawsuit for Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) announced by the Shareholders Foundation Update in Lawsuit for Investors who purchased shares of Veradigm Inc...

Update in Lawsuit for Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) announced by the Shareholders Foundation

Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, today announced that Dr. Yin Ho, Veradigm interim Chief Executive Officer, and Lee...

Veradigm to Participate in TD Cowen Annual Health Care Conference

Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, announced today that, as expected, it received a notice from The Nasdaq Stock Market LLC...

Veradigm Receives Expected Delisting Notice from Nasdaq

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Veradigm (NASDAQ:MDRX) Is Doing The Right Things To Multiply Its Share Price

Veradigm Inc. (NASDAQ: MDRX) (the Company), a leading provider of healthcare data and technology products and solutions, today announced that it has signed a definitive agreement to acquire...

Veradigm to Acquire ScienceIO

Veradigm Inc. (NASDAQ: MDRX) (the Company), a leading provider of healthcare data and technology products and solutions, announced today that the Company does not expect to have filed its Annual...

Veradigm Provides Update on its Financial Restatement Process

Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that it will be highlighting the new Veradigm Payer Insights solution at the ViVE 2024...

Veradigm to Highlight New EHR-Integrated Care Gap Alert Solution at ViVE 2024 Conference

Which region of the U.S. has the highest rates of hypertension, coronary artery disease and heart failure? The South, according to this analysis on cardiovascular disease (CVD) from Veradigm Inc...

Veradigm Reveals New Insights on the Prevalence of Cardiovascular Conditions in the U.S.

Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the launch of TRANSFORM VAX, an American College of Cardiology (ACC)-sponsored initiative...

Veradigm and American College of Cardiology Launch Influenza Vaccination Education Initiative to Improve Cardiovascular Health

Lawsuit Notice: Investors who lost money with Veradigm Inc. (NASDAQ: MDRX) shares should contact the Shareholders Foundation Lawsuit Notice: Investors who lost money with Veradigm Inc. (NASDAQ: MDRX...

Lawsuit Notice: Investors who lost money with Veradigm Inc. (NASDAQ: MDRX) shares should contact the Shareholders Foundation

Veradigm, Inc. engages in the provision of clinical, financial, and operational results services. It operates through the Provider and Veradigm segments. The Provider segment includes the hospitals and health systems, ambulatory, CarePort, FollowMyHealth, EPSiTM, EISClassics, and 2bPrecise strategic business units. The firm solutions include All EMRs, All Population Health Management, Patient Engagement, and Precision Medicine. The company was founded in 1986 and is headquartered in Chicago, IL.

Volume (M)	216,446.00
52-Wk High	$14.09
52-Wk Low	$5.01

MDRX Allscripts Healthcare Solutions Inc

About

Feed

News

Sentiment

Earnings

Fundamentals